Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples